Concurrent Imatinib and Radiation Therapy for Unresectable and Symptomatic Desmoid Tumors

Table 1

Summary of patient characteristics and response to treatment.

Age	Sex	Site	Symptoms	Radiation dose	Radiation toxicity	Imatinib toxicity	Symptom relief (days)	Follow-up (months)	Change in volume
52	M	R back	Pain	50 Gy in 25 fx	Grade 1 fatigue	Grade 2 nausea	7	12	−93%	PR
70	F	L axilla	Pain, weakness, and numbness	54 Gy in 27 fx	Grade 2 fatigue, Grade 1 dermatitis, L breast edema	Grade 2 fatigue, Grade 2 nausea	360	18	−69%	SD
47	F	L axilla	Pain and numbness	50.4 Gy in 28 fx	Grade 2 dermatitis, AVN of L humeral head	Grade 1 nausea	136	3	−8%	SD
63	M	R neck and upper back	Pain	50 Gy in 25 fx	Grade 2 dermatitis	Grade 2 nausea, Grade 2 dysgeusia	42	4	−28%	SD

M = male, F = female, R = right, L = left, and fx = fractions. on change in largest diameter, PR = partial response, SD = stable disease, and AVN = avascular necrosis.